Pamisel, Focus of Individual Investors... Stock Price Up 1.82%...
The search frequency for Pharmicell, known as the world's first bio-pharmaceutical company to develop stem cell therapeutics, has surged recently.
As of 10:31 AM on the 12th, Pharmicell's stock price rose 1.82% from the previous day to 22,400 KRW, with a trading volume of 5,254,652 shares, which is 114.48% of the 5-day average trading volume. Foreign investors are tentatively estimated to have net sold 216,000 shares today.
[Table] Net Trading Volume of Foreign and Institutional Investors (Unit: shares)
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
